H.R. 5844 (119th)Bill Overview

Harm Reduction Through Community Engagement Act of 2025

Health|Health
Cosponsors
Support
Democratic
Introduced
Oct 28, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for co…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill amends 21 U.S.C. 823(h) to add community-engagement, siting, reporting, and program-design requirements for practitioners registering to provide opioid maintenance or detoxification treatment. New criteria for registration include a half-mile buffer from schools, day cares, playgrounds, and other drug treatment facilities (including supervised injection facilities); a demonstrated patient-need justification; promotion of telehealth; designation of a community liaison; use or establishment of a local customer-relationship-management (CRM) system to track service requests; and regular reporting of treatment performance and telehealth outcomes to the Secretary.

Why people may split

Siting restrictions and inclusion of supervised injection facilities: liberals worry about access and harm-reduction impacts; conservatives view this as protective of community standards.

Watch point

Relative to its intended legislative type, this bill is a substantive amendment to the Controlled Substances Act that establishes new conditions for opioid treatment program registration focused on community engagement, siting, telehealth, data reporting, and community relations.

The bill amends 21 U.S.C. 823(h) to add community-engagement, siting, reporting, and program-design requirements for practitioners registering to provide opioid maintenance or detoxification treatment.

New criteria for registration include a half-mile buffer from schools, day cares, playgrounds, and other drug treatment facilities (including supervised injection facilities); a demonstrated patient-need justification; promotion of telehealth; designation of a community liaison; use or establishment of a local customer-relationship-management (CRM) system to track service requests; and regular reporting of treatment performance and telehealth outcomes to the Secretary.

It requires outreach, a neighborhood engagement plan, a community advisory board, and a community relations plan to address quality-of-life concerns such as loitering, open drug use, and unsafe disposal of needles.

Passage40/100

On substance alone, the bill is a narrowly focused statutory amendment that could be presented as increasing community accountability for opioid treatment programs—this helps its prospects relative to large, transformative legislation. However, it imposes multiple new operational requirements without authorizing funding, includes a strict proximity restriction and mentions supervised injection facilities (a politically sensitive term), and could prompt opposition from treatment providers and harm-reduction advocates. Those factors make enactment possible but not likely without negotiation, amendment, or funding offsets.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a substantive amendment to the Controlled Substances Act that establishes new conditions for opioid treatment program registration focused on community engagement, siting, telehealth, data reporting, and community relations. It also creates an annual reporting obligation to Congress, making study/reporting elements a clear secondary feature.

Contention55/100

Siting restrictions and inclusion of supervised injection facilities: liberals worry about access and harm-reduction impacts; conservatives view this as protective of community standards.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Local governmentsSchools · Local governments

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Local governmentsMay increase local stakeholder involvement and oversight of OTPs, potentially improving relations between clinics and c…
  • Potential benefitRequires systematic data collection and annual reporting to Congress on treatment performance and telehealth use, which…
  • Potential benefitPromoting telehealth and requiring OTPs to actively offer telehealth options could reduce travel burdens for some patie…
Likely burdened
  • Potential burdenAdds new regulatory and administrative requirements (outreach plans, advisory boards, CRM integration, data reporting)…
  • SchoolsThe half‑mile buffer from schools, daycares, playgrounds, and other treatment facilities may restrict where OTPs can op…
  • Local governmentsGiving local stakeholders formalized input and requiring OTPs to work with local CRM systems could allow de facto local…
03 · Why people split

Why the argument around this bill splits.

Siting restrictions and inclusion of supervised injection facilities: liberals worry about access and harm-reduction impacts; conservatives view this as protective of community standards.
Progressive55%

A mainstream progressive would see elements of the bill they like — telehealth expansion, performance reporting, and formalized community engagement — but would be wary of provisions that could restrict access or stigmatize patients.

The half-mile siting buffer and explicit reference to supervised injection facilities may be read as implicitly limiting harm-reduction sites and could worsen access in dense or underserved areas.

Requirements to work closely with law enforcement and to run CRM systems raise privacy and diversion-concern issues that could deter people with substance use disorders from seeking care.

Split reaction
Centrist70%

A pragmatic moderate would view the bill as a reasonable attempt to balance access to opioid treatment with community concerns.

They would appreciate structured community engagement, data collection, and telehealth promotion as tools to improve outcomes while addressing local quality-of-life issues.

They would be cautious about potential unintended access barriers (e.g., the half-mile buffer) and administrative costs and would look for clear implementation guidance and funding.

Leans supportive
Conservative80%

A mainstream conservative would generally favor the bill’s emphasis on protecting communities, local engagement, and avoiding clustering of treatment sites near schools and other sensitive locations.

The requirements for a community liaison, working with law enforcement, and concrete plans to address loitering, open drug use, and discarded needles align with priorities around public safety and local control.

They may have some reservations about additional federal reporting requirements or mandates that increase costs, but would likely view those as acceptable tradeoffs for stronger oversight and accountability.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

On substance alone, the bill is a narrowly focused statutory amendment that could be presented as increasing community accountability for opioid treatment programs—this helps its prospects relative to large, transformative legislation. However, it imposes multiple new operational requirements without authorizing funding, includes a strict proximity restriction and mentions supervised injection facilities (a politically sensitive term), and could prompt opposition from treatment providers and harm-reduction advocates. Those factors make enactment possible but not likely without negotiation, amendment, or funding offsets.

Scope and complexity
52%
Scopemoderate
52%
Complexitymedium
Why this could stall
  • The bill does not specify an appropriation mechanism or funding to help providers comply with new obligations (community liaisons, CRM systems, reporting); the presence or absence of subsequent funding proposals will materially affect stakeholder support and implementation feasibility.
  • The text refers generically to 'the Secretary' for determinations and reporting but does not explicitly name the agency or clarify cross-agency responsibilities (e.g., HHS, DEA, or another office), creating ambiguity about implementation authority.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Siting restrictions and inclusion of supervised injection facilities: liberals worry about access and harm-reduction impacts; conservatives…

On substance alone, the bill is a narrowly focused statutory amendment that could be presented as increasing community accountability for o…

Unlocked analysis

Relative to its intended legislative type, this bill is a substantive amendment to the Controlled Substances Act that establishes new conditions for opioid treatment program registration focused on community engagement,…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis